-
Innovation Ranking
Innovation Ranking – Penta-Ocean Construction Co Ltd
Penta-Ocean Construction Co Ltd (Penta-Ocean) is a civil engineering and general construction company. It offers a range of civil and architectural engineering services for various projects globally. Penta-Ocean offers its services for various projects including the construction of port and harbor, airport, power station, dam and river work, water supply and sewerage, bridge, railway and road and tunnel projects. It also offers construction services for the environmental facility, industrial and logistics, medical, health and welfare, recreational, office, commercial and lodging,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – STR-324 in Post-Operative Pain
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - STR-324 in Post-Operative Pain report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. STR-324 in Post-Operative Pain Drug Details: STR-324 is under development for...
-
Product Insights
Penta RE – Mlynske Nivy Office Complex – Bratislavsky
The Penta RE – Mlynske Nivy Office Complex – Bratislavsky project involves the construction of 32,500m2 office complex in Bratislava, Bratislavsky, Slovakia. Equip yourself with the essential tools needed to make informed and profitable decisions with our Penta RE – Mlynske Nivy Office Complex – Bratislavsky report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Selinexor in Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Selinexor in Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Selinexor in Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis) Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Selinexor in Wilms’ Tumor (Nephroblastoma)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Selinexor in Wilms' Tumor (Nephroblastoma) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Selinexor in Wilms' Tumor (Nephroblastoma) Drug Details: Selinexor (Xpovio, Nexpovio)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Selinexor in Atypical Teratoid Rhabdoid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Selinexor in Atypical Teratoid Rhabdoid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Selinexor in Atypical Teratoid Rhabdoid Tumor Drug Details: Selinexor...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Selinexor in Epithelial Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Selinexor in Epithelial Ovarian Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Selinexor in Epithelial Ovarian Cancer Drug Details: Selinexor (Xpovio, Nexpovio)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Selinexor in Mantle Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Selinexor in Mantle Cell Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Selinexor in Mantle Cell Lymphoma Drug Details: Selinexor (Xpovio, Nexpovio)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Selinexor in Osteosarcoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Selinexor in Osteosarcoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Selinexor in Osteosarcoma Drug Details: Selinexor (Xpovio, Nexpovio) is an antineoplastic agent....
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Selinexor in Leiomyosarcoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Selinexor in Leiomyosarcoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Selinexor in Leiomyosarcoma Drug Details: Selinexor (Xpovio, Nexpovio) is an antineoplastic agent....